The comparative genomics of human respiratory syncytial virus subgroups A and B: Genetic variability and molecular evolutionary dynamics

Journal of Virology

Volumn 87, Issue 14, 2013, Pages 8213-8226

  Tan, Lydia ^a   Coenjaerts, Frank E J ^a   Houspie, Lieselot ^b   Viveen, Marco C ^a   van Bleek, Grada M ^a   Wiertz, Emmanuel J H J ^a   Martin, Darren P ^c   Lemey, Philippe ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN G;

ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; EVOLUTIONARY RATE; FEMALE; G GENE; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; IMMUNE EVASION; MALE; MOLECULAR EVOLUTION; NASOPHARYNGEAL ASPIRATION; NONHUMAN; NOSE SMEAR; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEQUENCE ANALYSIS; STRAIN IDENTIFICATION; STRUCTURE ACTIVITY RELATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BAYES THEOREM; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOMICS; IMMUNE EVASION; LIKELIHOOD FUNCTIONS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PHYLOGENY; POPULATION DYNAMICS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SELECTION, GENETIC; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; VIRUS REPLICATION;

EID: 84880256565     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03278-12     Document Type: Article

References (74)

1. Henrickson KJ, Hoover S, Kehl KS, Hua W. 2004. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 23:S11-S18.
2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352:1749-1759.
3. Falsey AR, Walsh EE. 2000. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13:371-384.
4. Han LL, Alexander JP, Anderson LJ. 1999. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J. Infect. Dis. 179:25-30.
5. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simoes EA, Rudan I, Weber MW, Campbell H. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545-1555.
6. Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M. 2007. Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J. Clin. Microbiol. 45:3022-3030.
7. White LJ, Mandl JN, Gomes MG, Bodley-Tickell AT, Cane PA, Perez-Brena P, Aguilar JC, Siqueira MM, Portes SA, Straliotto SM, Waris M, Nokes DJ, Medley GF. 2007. Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models. Math Biosci. 209:222-239.
8. Meerhoff TJ, Paget JW, Kimpen JL, Schellevis F. 2009. Variation of respiratory syncytial virus and the relation with meteorological factors in different winter seasons. Pediatr. Infect. Dis. J. 28:860-866.
9. Cowton VM, McGivern DR, Fearns R. 2006. Unravelling the complexities of respiratory syncytial virus RNA synthesis. J. Gen. Virol. 87:1805-1821.
10. Batonick M, Wertz GW. 2011. Requirements for human respiratory syncytial virus glycoproteins in assembly and egress from infected cells. Adv. Virol. 2011:343-408.
11. Mitra R, Baviskar P, Duncan-Decocq RR, Patel D, Oomens AG. 2012. The human respiratory syncytial virus matrix protein is required for maturation of viral filaments. J. Virol. 86:4432-4443.
12. Hallak LK, Kwilas SA, Peeples ME. 2007. Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate. Methods Mol. Biol. 379:15-34.
13. Hallak LK, Spillmann D, Collins PL, Peeples ME. 2000. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74:10508-10513.
14. González-Reyes L, Ruiz-Arguello MB, Garcia-Barreno B, Calder L, Lopez JA, Albar JP, Skehel JJ, Wiley DC, Melero JA. 2001. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 98:9859-9864.
15. Techaarpornkul S, Barretto N, Peeples ME. 2001. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J. Virol. 75:6825-6834.
16. Gan SW, Ng L, Lin X, Gong X, Torres J. 2008. Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain. Protein Sci. 17:813-820.
17. Gan SW, Tan E, Lin X, Yu D, Wang J, Tan GM, Vararattanavech A, Yeo CY, Soon CH, Soong TW, Pervushin K, Torres J. 2012. The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels. J. Biol. Chem. 287:24671-24689.
18. Collins PL, Mottet G. 1993. Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus. J. Gen. Virol. 74(Pt 7):1445-1450.
19. Rixon HW, Brown G, Aitken J, McDonald T, Graham S, Sugrue RJ. 2004. The small hydrophobic (SH) protein accumulates within lipid-raft structures of the Golgi complex during respiratory syncytial virus infection. J. Gen. Virol. 85:1153-1165.
20. Lo MS, Brazas RM, Holtzman MJ. 2005. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79:9315-9319.
21. Bukreyev A, Yang L, Fricke J, Cheng L, Ward JM, Murphy BR, Collins PL. 2008. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J. Virol. 82:12191-12204.
22. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, Stone Y, McIntosh K. 1985. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect. Dis. 151:626-633.
23. Mufson MA, Orvell C, Rafnar B, Norrby E. 1985. Two distinct subtypes of human respiratory syncytial virus. J. Gen. Virol. 66(Pt 10):2111-2124.
24. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ. 1998. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J. Gen. Virol. 79(Pt 9):2221-2229.
25. Hall CB, Walsh EE, Long CE, Schnabel KC. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163:693-698.
26. Mufson MA, Belshe RB, Orvell C, Norrby E. 1987. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J. Clin. Microbiol. 25:1535-1539.
27. Johnson PR, Spriggs MK, Olmsted RA, Collins PL. 1987. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. U. S. A. 84:5625-5629.
28. Sullender WM. 2000. Respiratory syncytial virus genetic and antigenic diversity. Clin. Microbiol. Rev. 13:1-15.
29. Cane PA, Matthews DA, Pringle CR. 1994. Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J. Clin. Microbiol. 32:1-4.
30. Anderson LJ, Hendry RM, Pierik LT, Tsou C, McIntosh K. 1991. Multicenter study of strains of respiratory syncytial virus. J. Infect. Dis. 163:687-692.
31. Peret TC, Hall CB, Hammond GW, Piedra PA, Storch GA, Sullender WM, Tsou C, Anderson LJ. 2000. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J. Infect. Dis. 181:1891-1896.
32. Tang YW, Graham BS. 1997. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J. Clin. Invest. 99:2183-2191.
33. Klein Klouwenberg P, Tan L, Werkman W, van Bleek GM, Coenjaerts F. 2009. The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus. Crit. Rev. Immunol. 29:531-550.
34. Chin J, Magoffin RL, Shearer LA, Schieble JH, Lennette EH. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parain-fluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
35. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
36. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
37. Murphy BR, Walsh EE. 1988. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J. Clin. Microbiol. 26:1595-1597.
38. Castilow EM, Olson MR, Meyerholz DK, Varga SM. 2008. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. J. Virol. 82:2196-2207.
39. Kruijsen D, Bakkers MJ, van Uden NO, Viveen MC, van der Sluis TC, Kimpen JL, Leusen JH, Coenjaerts FE, van Bleek GM. 2010. Serum antibodies critically affect virus-specific CD4×/CD8×T cell balance during respiratory syncytial virus infections. J. Immunol. 185:6489-6498.
40. Kruijsen D, Schijf MA, Lukens MV, van Uden NO, Kimpen JL, Coenjaerts FE, van Bleek GM. 2011. Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV. Vaccine 29:2730-2741.
41. Olson MR, Varga SM. 2007. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. J. Immunol. 179:5415-5424.
42. Grenfell BT, Pybus OG, Gog JR, Wood JL, Daly JM, Mumford JA, Holmes EC. 2004. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303:327-332.
43. Zlateva KT, Lemey P, Moes E, Vandamme AM, Van Ranst M. 2005. Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J. Virol. 79:9157-9167.
44. Zlateva KT, Lemey P, Vandamme AM, Van Ranst M. 2004. Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment G glycoprotein. J. Virol. 78:4675-4683.
45. Holmes EC, Grenfell BT. 2009. Discovering the phylodynamics of RNA viruses. PLoS Comput. Biol. 5:e1000505. doi:10.1371/journal.pcbi.1000505.
46. Kumaria R, Iyer LR, Hibberd ML, Simoes EA, Sugrue RJ. 2011. Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected children. Virol. J. 8:372. doi:10.1186/1743-422X-8-372.
47. Rebuffo-Scheer C, Bose M, He J, Khaja S, Ulatowski M, Beck ET, Fan J, Kumar S, Nelson MI, Henrickson KJ. 2011. Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS One 6:e25468. doi:10.1371/journal.pone.0025468.
48. Tan L, Lemey P, Houspie L, Viveen MC, Jansen NJG, van Loon AM, Wiertz E, van Bleek GM, Martin DP, Coenjaerts FE. 2012. Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology. PLoS One 7:e51439. doi:10.1371/journal.pone.0051439.
49. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
50. Gupta R, Brunak S. 2002. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac. Symp. Biocomput. 2002:310-322.
51. Julenius K, Molgaard A, Gupta R, Brunak S. 2005. Prediction, conservation analysis, and structural characterization of mammalian mucintype O-glycosylation sites. Glycobiology 15:153-164.
52. Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P. 2010. RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 26:2462-2463.
53. Baek YH, Choi EH, Song MS, Pascua PN, Kwon HI, Park SJ, Lee JH, Woo SI, Ahn BH, Han HS, Hahn YS, Shin KS, Jang HL, Kim SY, Choi YK. 2012. Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea. Arch. Virol. 157:1039-1050.
54. Drummond A, Pybus OG, Rambaut A. 2003. Inference of viral evolutionary rates from molecular sequences. Adv. Parasitol. 54:331-358. 55. Guindon S, Delsuc F, Dufayard JF, Gascuel O. 2009. Estimating maximum likelihood phylogenies with PhyML. Methods Mol. Biol. 537:113-137.
55. Guindon S, Delsuc F, Dufayard JF, Gascuel O. 2009. Estimating maximum likelihood phylogenies with PhyML. Methods Mol. Biol. 537:113-137.
56. Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 29:1969-1973.
57. Baele G, Lemey P, Bedford T, Rambaut A, Suchard MA, Alekseyenko AV. 2012. Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty. Mol. Biol. Evol. 29:2157-2167.
58. Drummond AJ, Ho SY, Phillips MJ, Rambaut A. 2006. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4:e88. doi:10.1371/journal.pbio.0040088.
59. Shapiro B, Ho SY, Drummond AJ, Suchard MA, Pybus OG, Rambaut A. 2011. A Bayesian phylogenetic method to estimate unknown sequence ages. Mol. Biol. Evol. 28:879-887.
60. Ho SY, Phillips MJ, Cooper A, Drummond AJ. 2005. Time dependency of molecular rate estimates and systematic overestimation of recent divergence times. Mol. Biol. Evol. 22:1561-1568.
61. Drummond AJ, Suchard MA. 2008. Fully Bayesian tests of neutrality using genealogical summary statistics. BMC Genet. 9:68. doi:10.1186/1471-2156-9-68.
62. Siebenga JJ, Lemey P, Kosakovsky Pond SL, Rambaut A, Vennema H, Koopmans M. 2010. Phylodynamic reconstruction reveals norovirus GII. 4 epidemic expansions and their molecular determinants. PLoS Pathog. 6:e1000884. doi:10.1371/journal.ppat.1000884.
63. Kosakovsky Pond SL, Frost SD. 2005. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 22:1208-1222.
64. Lemey P, Minin VN, Bielejec F, Kosakovsky Pond SL, Suchard MA. 2012. A counting renaissance: combining stochastic mapping and empirical Bayes to quickly detect amino acid sites under positive selection. Bioinformatics 28:3248-3256.
65. Pond SK, Muse SV. 2005. Site-to-site variation of synonymous substitution rates. Mol. Biol. Evol. 22:2375-2385.
66. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. 2012. Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 8:e1002764. doi:10.1371/journal.pgen.1002764.
67. Wertheim JO, Worobey M. 2009. Relaxed selection and the evolution of RNA virus mucin-like pathogenicity factors. J. Virol. 83:4690-4694.
68. Zimmer G, Trotz I, Herrler G. 2001. N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus. J. Virol. 75: 4744-4751.
69. Bermingham A, Collins PL. 1999. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc. Natl. Acad. Sci. U. S. A. 96: 11259-11264.
70. Cheng X, Park H, Zhou H, Jin H. 2005. Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication. J. Virol. 79:13943-13952.
71. Ahmadian G, Randhawa JS, Easton AJ. 2000. Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism. EMBO J. 19: 2681-2689.
72. Woelk CH, Holmes EC. 2001. Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J. Mol. Evol. 52:182-192.
73. Spann KM, Collins PL, Teng MN. 2003. Genetic recombination during coinfection of two mutants of human respiratory syncytial virus. J. Virol. 77:11201-11211.
74. Gray RR, Pybus OG, Salemi M. 2011. Measuring the temporal structure in serially-sampled phylogenies. Methods Ecol. Evol. 2:437-445.